CEMIP has been linked to tumor progression and metastasis in different kinds of human cancers, including prostate carcinoma (9), colorectal tumors (10), hepatocellular carcinoma (11), breast carcinoma (12), gastric carcinoma (13) and oral squamous cell carcinoma (14), it acts as an oncogene, playing a vital role in the proliferation, migration and apoptosis in a variety of malignancies (15). The gene discussed is CEMIP; the disease is prostate carcinoma.